Infinita Life Science

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company located in San Mateo, CA, focused on developing novel fatty acid synthase (FASN) inhibitors. Their lead product candidate, denifanstat, is designed to treat metabolic dysfunction associated with metabolic-associated steatohepatitis (MASH) and is currently undergoing multiple phases of clinical trials. The company is exploring additional applications for FASN inhibitors, including treatment for acne and select cancer types. Denifanstat has received Breakthrough Therapy designation from the FDA for its potential in treating noncirrhotic MASH with moderate to advanced liver fibrosis. Generated from the website

Curegenix Inc is a biotechnology company based in Burlingame, CA, specializing in innovative research and development in the field of genetic therapies. With a focus on cutting-edge technologies, Curegenix Inc is dedicated to advancing medical treatments and improving patient outcomes through its groundbreaking scientific discoveries. Generated from their business information